PRPO - Precipio Inc logo

Precipio Inc

PRPO

Precipio Inc. develops and sells cancer diagnostic products, reagents, and services, focusing on blood cancer testing. Its offerings include proprietary cell culture media and genetic diagnostic panels, serving laboratories and biopharma clients in the U.S.

โš•๏ธ Healthcare NASDAQ Listed 2000 $ USD
$1,000 invested 20 years ago โ†’$139today

Score Overview

1 Year
Score
Net Growth-215.15%
Net TrendShrank
Net Income Consistencyโ€”
Rev Growth19.04%
Rev TrendGrew
Revenue Consistencyโ€”
5 Years
Score7.0
Net Growth86.62%
Net Trend60%
Net Income Consistencyโ€”
Rev Growth223.52%
Rev TrendEvery year
Revenue Consistencyโ€”
10 Years
Score
Net Growth84.98%
Net Trend70%
Net Income Consistency
Rev Growth18x
Rev TrendEvery year
Revenue Consistency
20 Years
Score3.2
Net Growth66.66%
Net Trend60%
Net Income Consistency
Rev Growth22.26%
Rev Trend60%
Revenue Consistency
All Time
Score
Net Growth86.79%
Net Trend58%
Net Income Consistency
Rev Growth10.61%
Rev Trend50%
Revenue Consistency

Explore the 2021 public Archive ranking โ†’

Where Precipio Inc has ranked, year by year

Measure
Fundamentals Window

Showing 10 years ranking history by HDB Score.

Has not reached the top 50 on HDB Score in any year we have ranked.

  • PRPO

2011: 86.7% ยท 2021: 89.9% ยท free through 2021 ยท longest runs

Net Income x Stock Price

Historical Returns

Historical Returns
PeriodPriceReturn
Last Price2026-11-17
$ 19.17โ€”
1 Year2025-11-17
$ 21.03-8.84%
5 Years2021-11-17
$ 40.60-52.78%
10 Years2016-11-17
$ 51.00-62.41%
20 Years2006-11-17
$ 137.85-86.09%

Prices are split & dividend adjusted. All values are reported in USD.

Fundamental Data

Reported in USD

Year
TTM$ 28M-$ 1M$ 3M
2025$ 24M-$ 363K$ 6M
2024$ 15M-$ 4M$ 1M
2023$ 15M-$ 5M$ 1M
2022$ 9M-$ 12M$ 3M
2021$ 8M-$ 8M$ 11M
2020$ 6M-$ 10M$ 2M
2019$ 3M-$ 13M$ 848K
2018$ 2M-$ 15M$ 381K
2017$ 1M-$ 20M$ 421K
2016$ 1M-$ 7M$ 110K
2015$ 1M-$ 32M$ 444K
2014$ 27M-$ 13M$ 1M
2013$ 27M-$ 15M$ 1M
2012$ 31M-$ 8M$ 4M
2011$ 31M-$ 9M$ 4M
2010$ 20M-$ 3M$ 3M
2009$ 22M-$ 1M$ 5M
2008$ 23M-$ 495K$ 4M
2007$ 23M-$ 2M$ 5M
2006$ 23M-$ 3M$ 5M
2005$ 25M-$ 14M$ 6M
2004$ 33M-$ 34M$ 1M
2003$ 33M-$ 22M$ 1M
2002$ 37M-$ 21M$ 13M
2001$ 38M-$ 7M$ 43M
IPO2000$ 25M-$ 8M$ 61M
PRPO - Precipio Inc logo

Precipio Inc fundamental performance

Between 2020 and 2025, revenue grew from $ 6M to $ 24M and net income went from -$ 10M to -$ 363K. Revenue increased in every one of those 5 years; net income in 3.

Between 2015 and 2025, revenue grew from $ 1M to $ 24M and net income went from -$ 32M to -$ 363K. Revenue increased in every one of those 10 years; net income in 7.

Precipio Inc currently holds a 20-year HDB Score of 3.2 out of 10. How the HDB Score is calculated.

Membership

Continue PRPOโ€™s history

The public Archive runs through 2021. Membership adds recent and current rankings.

  • Recent and current rankings across 5,187 companies
  • Compare companies with the latest data
  • Track your research shortlist in a portfolio

$149 / year

or $19/month

Continue with Membership

30-day money-back guarantee.

Explore other companies